Concepedia

Author

Tatiana Smolonogina

Institute of Experimental Medicine

Also Known As

Tatiana A Smolonogina, Tatiana A. Smolonogina, Tatiana Smolonogina

17

Publications

247

Citations

10

H-Index

18

Concepts

All Affiliations

Institute of Experimental MedicineCenters for Disease Control and PreventionResearch Institute of Influenza
TS

About

Tatiana Smolonogina is an author at Institute of Experimental Medicine specializing in influenza vaccines, vaccination, and virology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

8

8

183

2

Immunology

8

8

183

3

Allergy

2

2

35

4

Epidemiology

1

1

25

5

Emerging Infectious Diseases

1

1

12

Tatiana Smolonogina

×

10

Publications

223

Citations

10

H-Index

YearCitations

Broadly protective anti-hemagglutinin stalk antibodies induced by live attenuated influenza vaccine expressing chimeric hemagglutinin

Irina Isakova–Sivak, Daniil Korenkov, Tatiana Smolonogina,

Virology

2018

37

H7N9 Live Attenuated Influenza Vaccine Is Highly Immunogenic, Prevents Virus Replication, and Protects Against Severe Bronchopneumonia in Ferrets

Jørgen de Jonge, Irina Isakova–Sivak, Harry van Dijken,

Molecular Therapy

2016

34

Development and Pre-Clinical Evaluation of Two LAIV Strains against Potentially Pandemic H2N2 Influenza Virus

Irina Isakova–Sivak, Jørgen de Jonge, Tatiana Smolonogina,

PLoS ONE

2014

27

Comparative studies of infectivity, immunogenicity and cross-protective efficacy of live attenuated influenza vaccines containing nucleoprotein from cold-adapted or wild-type influenza virus in a mouse model

Irina Isakova–Sivak, Daniil Korenkov, Tatiana Smolonogina,

Virology

2016

26

H2N2 live attenuated influenza vaccine is safe and immunogenic for healthy adult volunteers

Irina Isakova–Sivak, Marina Stukova, Anatoly Naykhin,

Human Vaccines & Immunotherapeutics

2015

25

Immunogenicity and Cross Protection in Mice Afforded by Pandemic H1N1 Live Attenuated Influenza Vaccine Containing Wild-Type Nucleoprotein

Andrey Rekstin, Irina Isakova–Sivak, Galina Petukhova,

BioMed Research International

2017

24

Safety, immunogenicity and protection of A(H3N2) live attenuated influenza vaccines containing wild-type nucleoprotein in a ferret model

Daniil Korenkov, Karen Laurie, Patrick C. Reading,

Infection Genetics and Evolution

2018

14

Study of Neuraminidase-Inhibiting Antibodies in Clinical Trials of Live Influenza Vaccines

Yulia Desheva, Tatiana Smolonogina, Svetlana Donina,

Antibodies

2020

13

Anti-neuraminidase antibodies against pandemic A/H1N1 influenza viruses in healthy and influenza-infected individuals

Yulia Desheva, Ivan А. Sychev, Tatiana Smolonogina,

PLoS ONE

2018

12

Genotyping assay for differentiation of wild-type and vaccine viruses in subjects immunized with live attenuated influenza vaccine

Victoria Matyushenko, Irina Isakova–Sivak, Tatiana Smolonogina,

PLoS ONE

2017

11

Page 1